Dr BERTHET Cyril
Fiche personne
coordonnées
Oncodesign Biotechnology
20 rue Jean Mazen
BP 27627
21076 DIJON Cedex
+33 3 80 78 82 60
Territoire
Bourgogne
Statut
Chercheur
affiliation
Site web
Recherche
Expertises :
- Recherche:Pharmacologie
- Recherche:Modèle animaux
- Recherche:Imagerie
- Industrie:Service
Publications
IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice.
Hodge DL, Berthet C, Coppola V, Kastenmuller W, Buschman MD, Schaughency PM, Shirota H, Scarzello AJ, Subleski JJ, Anver MR, Ortaldo JR, Lin F, Reynolds DA, Sanford ME, Kaldis P, Tessarollo L, Klinman DM, Young HA
J Autoimmun. 2014 Sep;53:33-45
Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.
Julien S, Merino-Trigo A, Lacroix L, Pocard M, Goere D, Mariani P, Landron S, Bigot L, Nemati F, Dartigues P, Weiswald LB, Lantuas D, Morgand L, Pham E, Gonin P, Dangles-Marie V, Job B, Dessen P, Bruno A, Pierre A, De The H, Soliman H, Nunes M, Lardier G, Calvet L, Demers B, Prevost G, Vrignaud P, Roman-Roman S, Duchamp O, Berthet C
Clin Cancer Res. 2012 Oct 1;18(19):5314-28
Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo.
Hanse EA, Nelsen CJ, Goggin MM, Anttila CK, Mullany LK, Berthet C, Kaldis P, Crary GS, Kuriyama R, Albrecht JH
Cell Cycle. 2009 Sep 1;8(17):2802-9